Genetic variants confer susceptibility to urinary bladder cancer: An updated list of confirmed polymorphisms

EXCLI Journal

Volumn 11, Issue , 2012, Pages 743-747

  Selinski, Silvia ^a  

^a TU DORTMUND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; GLUTATHIONE TRANSFERASE M1; POLYCYCLIC AROMATIC HYDROCARBON;

ACETYLATION; APOPTOSIS; ATTRIBUTABLE RISK; BLADDER CANCER; CANCER PROGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE; DETOXIFICATION; EDITORIAL; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; NONHUMAN; OCCUPATIONAL EXPOSURE; POPULATION RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 84872919376     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Editorial

References (27)

1. Arand M, Mühlbauer R, Hengstler J, Jäger E, Fuchs J, Winkler L et al. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S- transferase GSTM1 and GSTT1 polymor- phisms. Anal Biochem 1996;236:184-6.
2. Binder H, Müller T, Schwender H, Golka K, Steffens M, Hengstler JG et al. Cluster- localized sparse logistic regression for SNP data. Stat Appl Genet Mol Biol 2012 Aug 14;11(4). pii:/j/sagmb.2012.11.issue- 4/1544-6115.1694/1544-6115.1694.xml. http://dx.doi.org/10.1515/1544-6115.1694
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon: International Agency for Research on Cancer, 2010. Available from: http://globocan.iarc.fr, accessed on Nov 09, 2012.
4. Fu YP, Kohaar I, Rothman N, Earl J, Figueroa JD, Ye Y et al. Common genetic vari- ants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A 2012;109:4974-4979.
5. Golka K, Prior V, Blaszkewicz M, Cascorbi I, Schöps W, Kierfeld G et al. Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany. Scand J Work Envi- ron Health 1996;22:332-338.
6. Golka K, Reckwitz T, Kempkes M, Cascorbi I I, Blaskewicz M, Reich SE et al. N-Acetyltransferase 2 (NAT2) and gluta- thione S-transferase μ (GSTM1) in bladder- cancer patients in a highly industrialized area. Int J Occup Environ Health 1997;3: 105-110.
7. Golka K, Prior V, Blaszkewicz M, Bolt HM. The enhanced bladder cancer suscep- tibility of NAT2 slow acetylators towards aromatic amines: a review considering eth- nic differences. Toxicol Lett 2002;128:229-241.
8. Golka K, Wiese A, Assennato G, Bolt HM. Occupational exposure and urological can- cer. World J Urol 2004;21:382-391.
9. Golka K, Hermes M, Selinski S, Blaszkewicz M, Bolt HM, Roth G et al. Suscep- tibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupa- tional exposure. Pharmacogenet Genom 2009;19:903-906.
10. Golka K, Selinski S, Lehmann ML, Blaszkewicz M, Marchan R, Ickstadt K et al. Ge- netic variants in urinary bladder cancer: collective power of the wimp SNPs. Arch Toxicol 2011;85:539-554.
11. Golka K, Kopps S, Prager HM, Mende S V, Thiel R, Jungmann O et al. Bladder cancer in crack testers applying azo dye-based sprays to metal bodies. J Toxicol Environ Health A 2012;75:566-71.
12. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008;40: 1307-12.
13. Kiemeney LA, Sulem P, Besenbacher S, Vermeulen SH, Sigurdsson A, Thorleifsson G et al. A sequence variant at 4p16.3 con- fers susceptibility to urinary bladder cancer. Nat Genet 2010;42:415-9.
14. Lehmann ML, Selinski S, Blaszkewicz M, Orlich M, Ovsiannikov D, Moormann O et al. Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk. Arch Toxicol 2010;84:967-78.
15. Menashe I, Figueroa JD, Garcia-Closas M, Chatterjee N, Malats N, Picornell A et al. Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European back- ground. PLoS One 2012;7:e29396.
16. Moore LE, Baris DR, Figueroa JD, GarciaClosas M, Karagas MR, Schwenn MR et al. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 metaanalysis. Carcinogenesis 2011;32:182-9.
17. Nørskov MS, Frikke-Schmidt R, Bojesen SE, Nordestgaard BG, Loft S, TybjærgHansen A. Copy number variation in gluta- thione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population. Pharmacogenomics J 2011;11:292-9.
18. Ovsiannikov D, Selinski S, Lehmann ML, Blaszkewicz M, Moormann O, Haenel MW et al. Polymorphic enzymes, urinary blad- der cancer risk, and structural change in the local industry. J Toxicol Environ Health A 2012;75:557-65.
19. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A et al. Se- quence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 2009;41:221-7.
20. Rafnar T, Vermeulen SH, Sulem P, Thorleifsson G, Aben KK, Witjes JA et al. Eu- ropean genome-wide association study identifies SLC14A1 as a new urinary blad- der cancer susceptibility gene. Hum Mol Genet 2011;20:4268-81.
21. Roth E, Selinski S, Schikowsky C, Seidel T, Volkert F, Blaszkewicz M et al. Bladder cancer survival in a former industrial area in Saxony-Anhalt, Germany. J Toxicol En- viron Health A 2012;75:1216-25.
22. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD et al. A multi-stage genome-wide association study of bladder cancer identifies multiple sus- ceptibility loci. Nat Genet 2010;42:978-84.
23. Schwender HR, Selinski S, Blaszkewicz M, Marchan R, Ickstadt K, Golka K et al. Di- stinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers. Plos One 2012; accepted.
24. Selinski S, Blaszkewicz M, Lehmann ML, Ovsiannikov D, Moormann O, Guballa C et al. Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype. Pharmacogenet Genomics 2011;21:673-8.
25. Selinski S, Lehmann ML, Blaszkewicz M, Ovsiannikov D, Moormann O, Guballa C et al. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk. Arch Toxicol 2012;86:1369-78.
26. Tang W, Fu YP, Figueroa JD, Malats N, Garcia-Closas M, Chatterjee N et al. Map- ping of the UGT1A locus identifies an un- common coding variant that affects mRNA expression and protects from bladder can- cer. Hum Mol Genet 2012;21:1918-30.
27. Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 2009;41:991-5. Erratum in Nat Genet 2009;41:1156.